EICHORCondition: Rheumatoid Arthritis (RA · Sponsor: University Hospital, Toulouse
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study aims to assess the feasibility of tapering JAK inhibitors in rheumatoid arthritis patients in low disease activity by comparing a group of patients tapering the JAK inhibitor dosage to a group of patients continuing the full-dose. Participants will: * Either take 1. JAK inhibitor dose-tapering strategy. 2. JAK inhibitor continuous therapy strategy. * Visit the clinic once every 3 months for checkups and tests * Keep a diary of their treatment intake and symptoms
This description comes directly from the study's public registry record.
Adeline RUYSSEN-WITRAND, MD · 05 61 77 56 26 · ruyssen-witrand.a@chu-toulouse.fr
Delphine THUILLEZ · 33 5 61 77 69 66 · thuillez.d@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| UH Toulouse | Toulouse, Occitanie, France | Recruiting |
| CHU d'Amiens | Amiens, France | Recruiting |
| Hôpital Pellegrin | Bordeaux, France | Recruiting |
| La Cavale Blanche | Brest, France | Recruiting |
| CHU de Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Le Mans | Le Mans, France | Recruiting |
| Hôpital Saint Philibert | Lille, France | Recruiting |
| CHU Dupuytren 2 | Limoges, France | Recruiting |
| Hôpital Sainte Marguerite | Marseille, France | Recruiting |
| Hôpital LAPEYRONIE | Montpellier, France | Recruiting |
| CHRU de Nancy | Nancy, France | Recruiting |
| Hôpital Pasteur 2 | Nice, France | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06687551